Annual long term debt:
$327.50M-$72.37M(-18.10%)Summary
- As of today (July 1, 2025), TVTX annual long term debt is $327.50 million, with the most recent change of -$72.37 million (-18.10%) on December 31, 2024.
- During the last 3 years, TVTX annual long term debt has risen by +$69.42 million (+26.90%).
- TVTX annual long term debt is now -18.75% below its all-time high of $403.06 million, reached on December 31, 2022.
Performance
TVTX Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$326.25M-$1.26M(-0.38%)Summary
- As of today (July 1, 2025), TVTX quarterly long term debt is $326.25 million, with the most recent change of -$1.26 million (-0.38%) on March 31, 2025.
- Over the past year, TVTX quarterly long term debt has dropped by -$72.73 million (-18.23%).
- TVTX quarterly long term debt is now -19.40% below its all-time high of $404.77 million, reached on March 31, 2022.
Performance
TVTX Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
TVTX Long term debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -18.1% | -18.2% |
3 y3 years | +26.9% | -19.4% |
5 y5 years | +59.9% | +57.3% |
TVTX Long term debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -18.8% | +26.9% | -19.3% | at low |
5 y | 5-year | -18.8% | +59.9% | -19.4% | +55.4% |
alltime | all time | -18.8% | +656.6% | -19.4% | +653.7% |
TVTX Long term debt History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $326.25M(-0.4%) |
Dec 2024 | $327.50M(-18.1%) | $327.50M(-0.3%) |
Sep 2024 | - | $328.54M(-17.5%) |
Jun 2024 | - | $398.06M(-0.2%) |
Mar 2024 | - | $398.98M(-0.2%) |
Dec 2023 | $399.88M(-0.8%) | $399.88M(-0.2%) |
Sep 2023 | - | $400.70M(-0.2%) |
Jun 2023 | - | $401.51M(-0.2%) |
Mar 2023 | - | $402.30M(-0.2%) |
Dec 2022 | $403.06M(+56.2%) | $403.06M(-0.1%) |
Sep 2022 | - | $403.38M(-0.2%) |
Jun 2022 | - | $404.05M(-0.2%) |
Mar 2022 | - | $404.77M(+56.8%) |
Dec 2021 | $258.08M(+5.9%) | $258.08M(+15.4%) |
Sep 2021 | - | $223.70M(+1.3%) |
Jun 2021 | - | $220.86M(+1.3%) |
Mar 2021 | - | $218.08M(-10.5%) |
Dec 2020 | $243.68M(+18.9%) | $243.68M(+14.6%) |
Sep 2020 | - | $212.65M(+1.3%) |
Jun 2020 | - | $210.01M(+1.3%) |
Mar 2020 | - | $207.41M(+1.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | $204.86M(+5.0%) | $204.86M(+1.2%) |
Sep 2019 | - | $202.35M(+1.2%) |
Jun 2019 | - | $199.89M(+1.2%) |
Mar 2019 | - | $197.47M(+1.2%) |
Dec 2018 | $195.09M(+332.8%) | $195.09M(+1.2%) |
Sep 2018 | - | $192.75M(+326.1%) |
Mar 2018 | - | $45.24M(+0.4%) |
Dec 2017 | $45.08M(+1.5%) | $45.08M(+0.4%) |
Sep 2017 | - | $44.91M(+0.4%) |
Jun 2017 | - | $44.75M(+0.4%) |
Mar 2017 | - | $44.58M(+0.4%) |
Dec 2016 | $44.42M(+1.5%) | $44.42M(+0.4%) |
Sep 2016 | - | $44.26M(+0.4%) |
Jun 2016 | - | $44.09M(+0.4%) |
Mar 2016 | - | $43.93M(+0.4%) |
Dec 2015 | $43.77M(+1.1%) | $43.77M(+0.0%) |
Sep 2015 | - | $43.75M(+0.4%) |
Jun 2015 | - | $43.59M(-48.3%) |
Mar 2015 | - | $84.24M(+94.6%) |
Dec 2014 | $43.29M | $43.29M(-48.0%) |
Sep 2014 | - | $83.29M(+0.6%) |
Jun 2014 | - | $82.81M |
FAQ
- What is Travere Therapeutics annual long term debt?
- What is the all time high annual long term debt for Travere Therapeutics?
- What is Travere Therapeutics annual long term debt year-on-year change?
- What is Travere Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Travere Therapeutics?
- What is Travere Therapeutics quarterly long term debt year-on-year change?
What is Travere Therapeutics annual long term debt?
The current annual long term debt of TVTX is $327.50M
What is the all time high annual long term debt for Travere Therapeutics?
Travere Therapeutics all-time high annual long term debt is $403.06M
What is Travere Therapeutics annual long term debt year-on-year change?
Over the past year, TVTX annual long term debt has changed by -$72.37M (-18.10%)
What is Travere Therapeutics quarterly long term debt?
The current quarterly long term debt of TVTX is $326.25M
What is the all time high quarterly long term debt for Travere Therapeutics?
Travere Therapeutics all-time high quarterly long term debt is $404.77M
What is Travere Therapeutics quarterly long term debt year-on-year change?
Over the past year, TVTX quarterly long term debt has changed by -$72.73M (-18.23%)